0.00Open0.04Pre Close0 Volume93 Open Interest75.00Strike Price0.00Turnover97.59%IV2.99%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type-0.0537Delta0.0624Gamma1931.75Leverage Ratio-0.4711Theta0.0000Rho-103.66Eff Leverage0.0020Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet